Current and future use of umifenovir in patients with COVID-19
At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental” nature of this treatment.
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
Izdatelstvo OKI
2020-10-01
|
| Seri Bilgileri: | Качественная клиническая практика |
| Konular: | |
| Online Erişim: | https://www.clinvest.ru/jour/article/view/532 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|